Description
Bioterrorism agent market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.90% in the above-mentioned research forecast period. Increase in incidence of emerging infectious diseases worldwide and advancement in bioengineering and genetic technologies.
Market Analysis and Insights: Global Bioterrorism Agent Market
Moreover development of novel vaccines and other biological therapies and presence of pipeline products also boost up the market growth. Moreover, vigorous research and development efforts and rising healthcare expenditure act as opportunity for the market growth. But, sometimes adverse effect related to the drugs, inadequate knowledge of the prevention option of emerging diseases and high cost of biological therapies may hamper the global bioterrorism agent market.
Bioterrorism is defined as the deliberate use of pathogenic microorganism strains involving bacteria, viruses and the toxin produced by them in order to spread the life- threatening diseases with an aim to attack a large population size. Increasing technological advancement, introduction of bioengineering field, advancement in genetic engineering technologies has paved the way for terrorist to use biological weapons for harming the population. Bioterrorism agents include anthrax (Bacillus anthracis), plague (Yersinia pestis), tularemia (Francisella tularensis) and botulism toxin, among others. Bioterrorism agents have been classified in category A, category B and category C on the basis of severity of risk they pose to national security. The emerging infectious disease such as Nipah virus, Hanta virus among others are accelerating the for market growth. Various manufacturers are working in order to overcome the threat arising from such threatening diseases by developing novel therapies such as vaccines, biological therapies, drugs among others.
Global Bioterrorism Agent Market Scope and Market Size
- On the basis of category, the bioterrorism agent market is segmented into category A, category B and category C.
- On the basis of product type, the bioterrorism agent market is segmented into drugs and devices.
- On the basis of application outlook, the bioterrorism agent market is segmented into military and civilian.
- On the basis of treatment type, the bioterrorism agent market is segmented into biological therapies, corticosteroids, vaccines, antibiotics.
- On the basis of end-users, the bioterrorism agent market is segmented into clinics, hospitals, academic and research institutes, others.
- On the basis of distribution channel, the bioterrorism agent market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy, others.
Bioterrorism Agent Market Country Level Analysis
Bioterrorism agent market is analysed and market size information is provided by country, category, product type, application outlook, treatment type, end-users and distribution channel as referenced above.
Bioterrorism is defined as the deliberate use of pathogenic microorganism strains involving bacteria, viruses and the toxin produced by them in order to spread the life- threatening diseases with an aim to attack a large population size. Increasing technological advancement, introduction of bioengineering field, advancement in genetic engineering technologies has paved the way for terrorist to use biological weapons for harming the population. Bioterrorism agents include anthrax (Bacillus anthracis), plague (Yersinia pestis), tularemia (Francisella tularensis) and botulism toxin, among others. Bioterrorism agents have been classified in category A, category B and category C on the basis of severity of risk they pose to national security. The emerging infectious disease such as Nipah virus, Hanta virus among others are accelerating the for market growth. Various manufacturers are working in order to overcome the threat arising from such threatening diseases by developing novel therapies such as vaccines, biological therapies, drugs among others.
According to WHO it is estimated that the cases of Hantavirus infection is increasing worldwide along with increasing cases of other infectious diseases. As these disease targets large population there is a great need of urgent prevention and treatment options and hence expected to provide market with the lucrative growth.
Global Bioterrorism Agent Market Scope and Market Size
- On the basis of category, the bioterrorism agent market is segmented into category A, category B and category C.
- On the basis of product type, the bioterrorism agent market is segmented into drugs and devices.
- On the basis of application outlook, the bioterrorism agent market is segmented into military and civilian.
- On the basis of treatment type, the bioterrorism agent market is segmented into biological therapies, corticosteroids, vaccines, antibiotics.
- On the basis of end-users, the bioterrorism agent market is segmented into clinics, hospitals, academic and research institutes, others.
- On the basis of distribution channel, the bioterrorism agent market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy, others.
Bioterrorism Agent Market Country Level Analysis
The countries covered in the bioterrorism agent market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America accounts the largest market share due to the advancement in genetic modification and bioengineering tools and favourable reimbursement policies for the biological therapies. Europe accounts the second largest market share due to increasing government support and increasing collaboration and partnership for development of novel therapies. Asia-Pacific is expected to account for the largest market share over coming years for the bioterrorism agent market as China is continuously producing bioterrorism agents for which manufacturers who are working for welfare of society are developing innovative and novel therapies against bioterrorism. Moreover presence of well-established vaccine production facilities in Japan and Australia among other is also expected to provide Asia-Pacific market with a lucrative growth.
Competitive Landscape and Bioterrorism Agent Market Share Analysis
Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to bioterrorism agent market.
The major players covered in the bioterrorism agent market are Evogen, Inc., Altimmune, Bavarian Nordic, Emergent BioSolutions Inc., Cleveland Bio Labs, Sanofi, Ology Bioservices, Ichor Medical Systems, Alnylam Pharmaceuticals, Inc., Chimerix, BioFactura, Inc., Immune Regulation Limited, XOMA Corporation, Elusys Therapeutics, Inc., Lanzhou Institute of Biological Products Co., Ltd, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Major TOC of the Bioterrorism Agent Market Report
Chapter One:
- MARKET SEGEMENTATION
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- MARKET OVERVIEW
Get TOC of the Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-bioterrorism-agent-market
Access Full Report:- https://www.databridgemarketresearch.com/reports/global-bioterrorism-agent-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
